Cargando…
The Role of Proteasome Inhibitors in Treating Acute Lymphoblastic Leukaemia
Acute lymphoblastic leukaemia (ALL) is an aggressive haematolymphoid malignancy. The prognosis of ALL is excellent in paediatric population, however the outcome of relapse/refractory disease is dismal. Adult ALL has less favourable prognosis and relapse/refractory disease is not uncommonly encounter...
Autores principales: | Sin, Chun-fung, Man, Pui-hei Marcus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733464/ https://www.ncbi.nlm.nih.gov/pubmed/35004327 http://dx.doi.org/10.3389/fonc.2021.802832 |
Ejemplares similares
-
Early T-Cell Precursor Acute Lymphoblastic Leukemia: Diagnosis, Updates in Molecular Pathogenesis, Management, and Novel Therapies
por: Sin, Chun-fung, et al.
Publicado: (2021) -
P351: PROTEASOME INHIBITORS INDUCE DNA DAMAGE AND MITOTIC CATASTROPHE IN ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL) VIA AUTOPHAGY-MEDIATED DEGRADATION OF WEE1
por: Fung Sin, Chun, et al.
Publicado: (2023) -
The Protozoan Inhibitor Atovaquone Affects Mitochondrial Respiration and Shows In Vitro Efficacy Against Glucocorticoid-Resistant Cells in Childhood B-Cell Acute Lymphoblastic Leukaemia
por: Sbirkov, Yordan, et al.
Publicado: (2021) -
What Role for Angiogenesis in Childhood Acute Lymphoblastic Leukaemia?
por: Schneider, P., et al.
Publicado: (2011) -
Role of apoptotic markers in paediatric acute lymphoblastic leukaemia
por: Kapoor, Gauri, et al.
Publicado: (2018)